20203178|t|Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions.
20203178|a|Increasing evidence suggests that phosphorylation may play an important role in the oligomerization, fibrillogenesis, Lewy body (LB) formation, and neurotoxicity of alpha-synuclein (alpha-syn) in Parkinson disease. Herein we demonstrate that alpha-syn is phosphorylated at S87 in vivo and within LBs. The levels of S87-P are increased in brains of transgenic (TG) models of synucleinopathies and human brains from Alzheimer disease (AD), LB disease (LBD), and multiple system atrophy (MSA) patients. Using antibodies against phosphorylated alpha-syn (S129-P and S87-P), a significant amount of immunoreactivity was detected in the membrane in the LBD, MSA, and AD cases but not in normal controls. In brain homogenates from diseased human brains and TG animals, the majority of S87-P alpha-syn was detected in the membrane fractions. A battery of biophysical methods were used to dissect the effect of S87 phosphorylation on the structure, aggregation, and membrane-binding properties of monomeric alpha-syn. These studies demonstrated that phosphorylation at S87 expands the structure of alpha-syn, increases its conformational flexibility, and blocks its fibrillization in vitro. Furthermore, phosphorylation at S87, but not S129, results in significant reduction of alpha-syn binding to membranes. Together, our findings provide novel mechanistic insight into the role of phosphorylation at S87 and S129 in the pathogenesis of synucleinopathies and potential roles of phosphorylation in alpha-syn normal biology.
20203178	19	22	S87	ProteinMutation	tmVar:p|Allele|S|87;VariantGroup:0;CorrespondingGene:6622;CorrespondingSpecies:9606
20203178	38	55	synucleinopathies	Disease	MESH:D000080874
20203178	66	81	alpha-synuclein	Gene	6622
20203178	265	274	Lewy body	Disease	MESH:D020961
20203178	276	278	LB	Disease	MESH:D020961
20203178	295	308	neurotoxicity	Disease	MESH:D020258
20203178	312	327	alpha-synuclein	Gene	6622
20203178	329	338	alpha-syn	Gene	6622
20203178	343	360	Parkinson disease	Disease	MESH:D010300
20203178	389	398	alpha-syn	Gene	6622
20203178	420	423	S87	ProteinMutation	tmVar:p|Allele|S|87;VariantGroup:0;CorrespondingGene:6622;CorrespondingSpecies:9606
20203178	521	538	synucleinopathies	Disease	MESH:D000080874
20203178	543	548	human	Species	9606
20203178	561	578	Alzheimer disease	Disease	MESH:D000544
20203178	580	582	AD	Disease	MESH:D000544
20203178	585	595	LB disease	Disease	MESH:D020961
20203178	597	600	LBD	Disease	MESH:D020961
20203178	607	630	multiple system atrophy	Disease	MESH:D019578
20203178	632	635	MSA	Disease	MESH:D019578
20203178	637	645	patients	Species	9606
20203178	687	696	alpha-syn	Gene	6622
20203178	698	704	S129-P	ProteinMutation	tmVar:p|SUB|S|129|P;HGVS:p.S129P;VariantGroup:1;CorrespondingGene:6622;CorrespondingSpecies:9606
20203178	709	714	S87-P	ProteinMutation	tmVar:p|SUB|S|87|P;HGVS:p.S87P;VariantGroup:0;CorrespondingGene:6622;CorrespondingSpecies:9606
20203178	794	797	LBD	Disease	MESH:D020961
20203178	799	802	MSA	Disease	MESH:D019578
20203178	808	810	AD	Disease	MESH:D000544
20203178	880	885	human	Species	9606
20203178	931	940	alpha-syn	Gene	6622
20203178	1049	1052	S87	ProteinMutation	tmVar:p|Allele|S|87;VariantGroup:0;CorrespondingGene:6622;CorrespondingSpecies:9606
20203178	1145	1154	alpha-syn	Gene	6622
20203178	1207	1210	S87	ProteinMutation	tmVar:p|Allele|S|87;VariantGroup:0;CorrespondingGene:6622;CorrespondingSpecies:9606
20203178	1236	1245	alpha-syn	Gene	6622
20203178	1361	1364	S87	ProteinMutation	tmVar:p|Allele|S|87;VariantGroup:0;CorrespondingGene:6622;CorrespondingSpecies:9606
20203178	1374	1378	S129	ProteinMutation	tmVar:p|Allele|S|129;VariantGroup:1;CorrespondingGene:6622;CorrespondingSpecies:9606
20203178	1416	1425	alpha-syn	Gene	6622
20203178	1541	1544	S87	ProteinMutation	tmVar:p|Allele|S|87;VariantGroup:0;CorrespondingGene:6622;CorrespondingSpecies:9606
20203178	1549	1553	S129	ProteinMutation	tmVar:p|Allele|S|129;VariantGroup:1;CorrespondingGene:6622;CorrespondingSpecies:9606
20203178	1577	1594	synucleinopathies	Disease	MESH:D000080874
20203178	1637	1646	alpha-syn	Gene	6622
20203178	Association	MESH:D000080874	CorrespondingGene:6622;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
20203178	Association	MESH:D020961	HGVS:p.S129P;CorrespondingGene:6622
20203178	Association	MESH:D000544	HGVS:p.S129P;CorrespondingGene:6622
20203178	Positive_Correlation	MESH:D019578	HGVS:p.S87P;CorrespondingGene:6622
20203178	Association	MESH:D000080874	CorrespondingGene:6622;CorrespondingSpecies:9606;VariantGroup:1;tmVar:p
20203178	Positive_Correlation	MESH:D019578	HGVS:p.S129P;CorrespondingGene:6622
20203178	Association	MESH:D020961	HGVS:p.S87P;CorrespondingGene:6622
20203178	Association	MESH:D000544	HGVS:p.S87P;CorrespondingGene:6622
20203178	Association	MESH:D020961	CorrespondingGene:6622;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
20203178	Association	MESH:D010300	6622
20203178	Association	MESH:D019578	6622
20203178	Association	MESH:D000080874	HGVS:p.S129P;CorrespondingGene:6622
20203178	Association	MESH:D020961	6622
20203178	Association	MESH:D000080874	6622
20203178	Association	MESH:D020961	6622
20203178	Association	MESH:D000544	6622
20203178	Association	MESH:D019578	6622

